Close

Proteostasis Therapeutics (PTI) Announces Withdrawal of Equity Offering Due to Market Conditions

March 21, 2018 6:28 AM EDT Send to a Friend
Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login